ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Testosterone treatment of prostate cancer survivors (SPIRIT Trial)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 235030" data-attributes="member: 13851"><p><em><strong>The study enrollment in the trial started in March 2019. Due to the global COVID19 Pandemic, all clinical research activities were halted in the US in March 2020. After 7- months of a complete shutdown of non-Covid-related research, there was a gradual return to limited study activities until the reactivation of in-person study activities in early 2021. Participant recruitment in 2021 remained low due to the reluctance of middle-aged and older adults to come to the medical centers for research visits due to the fear of contracting the infection. <u>Nevertheless, we have retained 89% of randomized participants in the study, and 97% of subjects who started the intervention adhered to all study procedures</u>.</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 235030, member: 13851"] [I][B]The study enrollment in the trial started in March 2019. Due to the global COVID19 Pandemic, all clinical research activities were halted in the US in March 2020. After 7- months of a complete shutdown of non-Covid-related research, there was a gradual return to limited study activities until the reactivation of in-person study activities in early 2021. Participant recruitment in 2021 remained low due to the reluctance of middle-aged and older adults to come to the medical centers for research visits due to the fear of contracting the infection. [U]Nevertheless, we have retained 89% of randomized participants in the study, and 97% of subjects who started the intervention adhered to all study procedures[/U].[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Testosterone treatment of prostate cancer survivors (SPIRIT Trial)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top